Rodino-Klapac Louise sold SRPT
March 3, 2025 · Form 4 insider transaction
Rodino-Klapac Louise sold 715 shares of Sarepta Therapeutics, Inc. at $103.77 per share, a transaction worth $74.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
715
Price
$103.77
Total value
$74.2K
InsiderRodino-Klapac Louise
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 3, 2025
Filing dateMarch 4, 2025
Shares owned after67,026
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.; Amount of Securities Beneficially Owned includes 111 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025.